-
MMP-2-Responsive Liposomes for Breast Cancer Immunotherapy
2026-09-15
The reference study develops NLG919@Lip-pep1, an MMP-2-responsive liposome designed to deliver a PD-1/PD-L1 blockade peptide before exposing an IDO inhibitor for tumor-cell targeting. Its main contribution is a cascade-targeting strategy that coordinates checkpoint release, T-cell reactivation, and immunosuppressive microenvironment remodeling in breast cancer models.
-
Praeruptorin A: Applied Research Workflows
2026-09-15
Turn Praeruptorin A from a multi-target natural product into a disciplined experimental tool for ferroptosis, inflammatory barrier injury, cardiomyopathy, and tumor invasion studies. This workflow emphasizes solvent control, orthogonal readouts, and careful separation of product-backed parameters from hypotheses adapted from related literature.
-
Z-VAD-FMK in Apoptosis and Pyroptosis Assays
2026-09-14
Z-VAD-FMK is an irreversible, cell-permeable pan-caspase inhibitor that can do more than suppress apoptosis: it can serve as a mechanistic boundary condition in mixed cell-death assays. This guide shows how to pair caspase blockade with pyroptosis-aware readouts for stronger apoptotic pathway research.
-
Ertapenem Sodium Salt for Resistance Profiling
2026-09-14
Ertapenem sodium salt supports reproducible susceptibility testing, phenotype–genotype correlation, and carbapenem resistance research without substituting for molecular confirmation. This workflow shows how to connect MIC data with plasmid, chromosome, and transmission findings from carbapenem-resistant Enterobacter cloacae.
-
PXR Activation, Liver Regeneration, and CYP Activity
2026-09-13
The reference study shows that activating pregnane X receptor (PXR) in rats can enlarge and regenerate the liver while also increasing the functional activity and protein expression of selected CYP enzymes. Its central contribution is the demonstration that structural liver adaptation and metabolic capacity can occur together, including after partial hepatectomy.
-
OM-MSCs, Golgi Stress, and Stroke Recovery
2026-09-12
This study identifies a mechanistic link between olfactory mucosa mesenchymal stem cells, Golgi apparatus stress, and cerebral ischemia/reperfusion injury through the PEDF–PI3K/Akt/mTOR axis. Its combination of OGD/R and MCAO models, PEDF knockdown, and pathway-inhibitor experiments provides a framework for studying organelle stress and neuroprotection.
-
Indomethacin as an Orthogonal Tool in Renal Inflammation
2026-09-12
Indomethacin offers translational researchers more than cyclooxygenase inhibition: it provides a layered perturbation strategy spanning prostanoid biology, PPAR signaling, lipid metabolism, and membrane organization. This article places the compound alongside recent FXR–KLF11 research in contrast-induced acute kidney injury to clarify what Indomethacin can test, what it cannot establish, and how to design more informative inflammation studies.
-
DDM, Integrin Dynamics, and Translational Structure
2026-09-11
Full-length αvβ3 integrin is a conformational ensemble, not a single druggable shape. This thought-leadership guide explains how n-Dodecyl-β-D-maltoside can be used as a controlled experimental variable to connect membrane protein solubilization, cryo-EM quality, ligand-state interpretation, and translational decision-making.
-
Sex Differences in Angiotensin II Hypertension
2026-09-11
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this dimorphism to gonadal hormone effects, sex-specific reflex adaptation, and sympathetic contributions to blood pressure maintenance.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-10
Use ARCA EGFP mRNA (5-moUTP) as a rapid, fluorescence-based transfection control for comparing delivery reagents, cell conditions, and assay timing in mammalian cells. Its oriented cap, modified uridine chemistry, and optimized poly(A) tail support reproducible EGFP expression while making storage and troubleshooting decisions more systematic.
-
2-APB Calcium Signaling Workflows
2026-09-10
Use 2-APB to separate IP3R-dependent calcium release, store-operated calcium entry, and channel-driven signals in cell-based experiments. This practical guide combines concentration planning, assay controls, troubleshooting, and a cautious comparison with the PLCβ3 mechanism highlighted in the reference study.
-
Thioguanine Workflows for Cancer and EV71 Studies
2026-09-09
Build reproducible 6-thioguanine experiments across cancer-cell, antiviral, and epigenetic models with practical guidance on dosing, controls, and orthogonal readouts. The workflow also adapts lessons from a classic genetic-toxicology study without confusing its glutaraldehyde findings with direct Thioguanine evidence.
-
A-769662: Reading AMPK Under Energy Stress
2026-09-09
A-769662 is a reversible AMPK activator for dissecting metabolic signaling without equating pharmacological activation with cellular energy starvation. This article translates new AMPK–ULK1 findings into practical assay design, controls, and interpretation for metabolism and proteasome studies.
-
Marein Reverses ABCG2-Mediated Chemoresistance
2026-09-08
The reference study identifies marein, a chalcone-type flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug transporter. By increasing intracellular exposure to ABCG2 substrates, marein restored cancer-cell sensitivity to mitoxantrone, topotecan, and olaparib, supporting transporter-focused strategies for studying multidrug resistance.
-
Omeprazole A2845: Research Workflow Guide
2026-09-08
Omeprazole A2845 provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity study workflows, and related assay development. Its limited water and ethanol solubility requires DMSO-based preparation and vehicle controls; it is intended only for scientific research and not for diagnostic, therapeutic, or medical use.